
Dale R. Miller
Examiner (ID: 5360, Phone: (571)272-6146 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 838 |
| Issued Applications | 502 |
| Pending Applications | 84 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16428259
[patent_doc_number] => 10828320
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Ophthalmic compositions with improved dessication protection and retention
[patent_app_type] => utility
[patent_app_number] => 16/721443
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3535
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721443
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/721443 | Ophthalmic compositions with improved dessication protection and retention | Dec 18, 2019 | Issued |
Array
(
[id] => 20621612
[patent_doc_number] => 12589106
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-31
[patent_title] => Nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier
[patent_app_type] => utility
[patent_app_number] => 17/416573
[patent_app_country] => US
[patent_app_date] => 2019-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7364
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416573 | Nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier | Dec 10, 2019 | Issued |
Array
(
[id] => 19440021
[patent_doc_number] => 12090248
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Crosslinked hyaluronic acid, hyaluronic acid hydrogel, and method for producing crosslinked hyaluronic acid and hyaluronic acid hydrogel
[patent_app_type] => utility
[patent_app_number] => 17/311070
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14362
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17311070
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/311070 | Crosslinked hyaluronic acid, hyaluronic acid hydrogel, and method for producing crosslinked hyaluronic acid and hyaluronic acid hydrogel | Dec 5, 2019 | Issued |
Array
(
[id] => 18724269
[patent_doc_number] => 20230338403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => COMPOSITION COMPRISING 2'-FL AND DFL FOR USE IN A METHOD FOR REDUCING PAIN
[patent_app_type] => utility
[patent_app_number] => 17/798270
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9278
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798270
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/798270 | COMPOSITION COMPRISING 2'-FL AND DFL FOR USE IN A METHOD FOR REDUCING PAIN | Dec 5, 2019 | Pending |
Array
(
[id] => 17533705
[patent_doc_number] => 20220112314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => ULTRASOUND AND PRESSURE ASSISTED METHOD FOR EXTRACTING PECTIN RICH IN RG-I
[patent_app_type] => utility
[patent_app_number] => 17/267487
[patent_app_country] => US
[patent_app_date] => 2019-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267487
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/267487 | Ultrasound and pressure assisted method for extracting pectin rich in RG-I | Dec 2, 2019 | Issued |
Array
(
[id] => 15765917
[patent_doc_number] => 20200113976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => RAPID-ACTING INSULIN FORMULATION COMPRISING A SUBSTITUTED ANIONIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/687339
[patent_app_country] => US
[patent_app_date] => 2019-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16687339
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/687339 | Rapid-acting insulin formulation comprising a substituted anionic compound | Nov 17, 2019 | Issued |
Array
(
[id] => 17356677
[patent_doc_number] => 20220017473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => INDAZOLYLCYANOETHYLAMINO COMPOUND, COMPOSITIONS OF SAME, METHOD OF MAKING, AND METHODS OF USING THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/294761
[patent_app_country] => US
[patent_app_date] => 2019-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17294761
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/294761 | Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof | Nov 13, 2019 | Issued |
Array
(
[id] => 19969673
[patent_doc_number] => 12338265
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Crosslinked artificial nucleic acid ALNA
[patent_app_type] => utility
[patent_app_number] => 17/292963
[patent_app_country] => US
[patent_app_date] => 2019-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36537
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292963
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/292963 | Crosslinked artificial nucleic acid ALNA | Nov 10, 2019 | Issued |
Array
(
[id] => 17065796
[patent_doc_number] => 20210268011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => AMPK ACTIVATING AGENT
[patent_app_type] => utility
[patent_app_number] => 16/759818
[patent_app_country] => US
[patent_app_date] => 2019-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16759818
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/759818 | AMPK activating agent | Nov 9, 2019 | Issued |
Array
(
[id] => 17334560
[patent_doc_number] => 20220000891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => METHODS OF SUPPORTING GASTROINTESTINAL HOMEOSTASIS
[patent_app_type] => utility
[patent_app_number] => 17/291481
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81606
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291481
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/291481 | Methods of supporting gastrointestinal homeostasis | Nov 7, 2019 | Issued |
Array
(
[id] => 18994588
[patent_doc_number] => 11911405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Methods of selectively modulating gastrointestinal microbial growth
[patent_app_type] => utility
[patent_app_number] => 17/292132
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 50
[patent_no_of_words] => 98863
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/292132 | Methods of selectively modulating gastrointestinal microbial growth | Nov 7, 2019 | Issued |
Array
(
[id] => 19256310
[patent_doc_number] => 12016334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Composition comprising sulphated galactose, and implementations thereof
[patent_app_type] => utility
[patent_app_number] => 16/955326
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 17438
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955326
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955326 | Composition comprising sulphated galactose, and implementations thereof | Nov 7, 2019 | Issued |
Array
(
[id] => 16492361
[patent_doc_number] => 10858386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Drug compound and purification methods thereof
[patent_app_type] => utility
[patent_app_number] => 16/674786
[patent_app_country] => US
[patent_app_date] => 2019-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 37769
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16674786
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/674786 | Drug compound and purification methods thereof | Nov 4, 2019 | Issued |
Array
(
[id] => 15831881
[patent_doc_number] => 20200131222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => COMPOSITION FOR ENHANCING EXERCISE ABILITY OR ANTI-FATIGUE COMPRISING NOVEL GINSENOSIDE
[patent_app_type] => utility
[patent_app_number] => 16/666586
[patent_app_country] => US
[patent_app_date] => 2019-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9621
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16666586
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/666586 | Composition for enhancing exercise ability or anti-fatigue comprising novel ginsenoside | Oct 28, 2019 | Issued |
Array
(
[id] => 17073730
[patent_doc_number] => 11110109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Water soluble O-glycosyl flavonoid compositions and methods for preparing same
[patent_app_type] => utility
[patent_app_number] => 16/660111
[patent_app_country] => US
[patent_app_date] => 2019-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3367
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16660111
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/660111 | Water soluble O-glycosyl flavonoid compositions and methods for preparing same | Oct 21, 2019 | Issued |
Array
(
[id] => 17297823
[patent_doc_number] => 20210393662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => USE OF SGLT2 INHIBITORS TO TREAT PRIMARY SCLEROSING CHOLANGITIS
[patent_app_type] => utility
[patent_app_number] => 17/285675
[patent_app_country] => US
[patent_app_date] => 2019-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17285675
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/285675 | USE OF SGLT2 INHIBITORS TO TREAT PRIMARY SCLEROSING CHOLANGITIS | Oct 16, 2019 | Abandoned |
Array
(
[id] => 15800103
[patent_doc_number] => 20200123194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => COMPOSITION COMPRISING NOVEL GINSENOSIDE
[patent_app_type] => utility
[patent_app_number] => 16/656029
[patent_app_country] => US
[patent_app_date] => 2019-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16656029
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/656029 | Composition comprising novel ginsenoside | Oct 16, 2019 | Issued |
Array
(
[id] => 19808290
[patent_doc_number] => 12239649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Dietary fiber for treating patients suffering from methylmalonic acidemia and propionic acidemia
[patent_app_type] => utility
[patent_app_number] => 17/281598
[patent_app_country] => US
[patent_app_date] => 2019-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9536
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17281598
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/281598 | Dietary fiber for treating patients suffering from methylmalonic acidemia and propionic acidemia | Sep 30, 2019 | Issued |
Array
(
[id] => 17334564
[patent_doc_number] => 20220000895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => NEW AGENTS FOR USE IN THE TREATMENT OF CARDIAC ARRHYTHMIA
[patent_app_type] => utility
[patent_app_number] => 17/281276
[patent_app_country] => US
[patent_app_date] => 2019-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4375
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17281276
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/281276 | Agents for use in the treatment of cardiac arrhythmia | Sep 29, 2019 | Issued |
Array
(
[id] => 17383753
[patent_doc_number] => 20220031605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => TARGETED DRUG DELIVERY SYSTEM TO BE USED IN TREATING OSTEOMYELITIS
[patent_app_type] => utility
[patent_app_number] => 17/278467
[patent_app_country] => US
[patent_app_date] => 2019-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1491
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17278467
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/278467 | TARGETED DRUG DELIVERY SYSTEM TO BE USED IN TREATING OSTEOMYELITIS | Sep 22, 2019 | Abandoned |